BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Micrologix Biotech Inc. (MGIXF) Third Quarter Results Conference Call & Web Cast Notification


10/19/2005 5:10:21 PM

VANCOUVER, March 8 /PRNewswire-FirstCall/ -- Micrologix Biotech Inc. (TSX: MBI; OTC: MGIXF) will host a conference call and web cast on Thursday, March 11, 2004 at 9:00 a.m. ET (6:00 a.m. PT) to discuss financial results for the third quarter ended January 31, 2004 and provide an update on company activities. To participate in the conference call, please dial 416-405-9310 or

1-877-211-7911. The call will be available for replay until March 25, 2004 by calling 1-800-408-3053 or 416-695-5800 and entering the pass code 3009242. The live and archived web cast can be accessed through the company's website at http://www.mbiotech.com/.

About Micrologix

Micrologix Biotech Inc. is engaged in the research, development, and commercialization of drugs that advance therapy, improve health, and enrich lives. The Company's focus is toward anti-infective drug development with four product candidates in human clinical development, multiple product opportunities in preclinical development, and several early-stage technologies in various stages of research and evaluation.

Micrologix Biotech Inc.

CONTACT: Investor & Media Relations Contacts: JonathanBurke, Micrologix Biotech Inc., Telephone: (604) 221-9666 Extension 241,Email: jburke@mbiotech.com; Gino de Jesus or Dian Griesel, Ph.D, TheInvestor Relations Group, Telephone: (212) 825-3210, Email:theproteam@aol.com;To request a free copy of this organization's annual report, please go tohttp://www.newswire.ca/ and click on reports@cnw.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES